AG˹ٷ

STOCK TITAN

[Form 4] Phibro Animal Health Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Judith Weinstein, Senior Vice President, General Counsel and Corporate Secretary of Phibro Animal Health Corp (PAHC), was granted 3,447 restricted stock units (RSUs) on 08/15/2025. Each RSU represents a contingent right to receive one share of Class A common stock and the reported ownership following the grant is 3,447 shares (direct). The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to continued employment through each vesting date. The Form 4 was signed and dated 08/19/2025.

Judith Weinstein, Senior Vice President, General Counsel e Corporate Secretary di Phibro Animal Health Corp (PAHC), ha ricevuto in data 15/08/2025 3.447 unità azionarie vincolate (RSU). Ogni RSU dà diritto, al verificarsi della condizione prevista, a ricevere una azione di classe A e, dopo la concessione, la partecipazione segnalata è di 3.447 azioni (dirette). Le RSU maturano in quote sostanzialmente uguali in ciascuno dei primi tre anniversari dell'1 agosto 2025, subordinatamente alla permanenza in servizio fino a ciascuna data di maturazione. Il Modulo 4 è stato firmato e datato 19/08/2025.

Judith Weinstein, Senior Vice President, General Counsel y Corporate Secretary de Phibro Animal Health Corp (PAHC), recibió el 15/08/2025 3.447 unidades de acciones restringidas (RSU). Cada RSU confiere el derecho contingente a recibir una acción de la clase A y la tenencia reportada tras la concesión es de 3.447 acciones (directas). Las RSU se consolidan en partes aproximadamente iguales en cada uno de los tres primeros aniversarios del 1 de agosto de 2025, condicionadas a la continuidad en el puesto hasta cada fecha de consolidación. El Formulario 4 fue firmado y fechado el 19/08/2025.

주디� 와인스타�은 Phibro Animal Health Corp (PAHC)� 수석부사장 � 법무총괄·회사 비서로서 2025� 8� 15일에 3,447개의 제한부 주식 단위(RSU)� 부여받았습니다. � RSU� 조건부� 클래� A 보통� 1주를 수령� 권리� 의미하며, 부� � 신고� 보유 주식은 3,447�(직접 보유)입니�. RSU� 2025� 8� 1일을 기준으로 � 3� 기념� 각각� 거의 동일� 비율� 베스팅되�, � 베스팅일� 계속 고용 상태� 있어� 합니�. Form 4� 2025� 8� 19� 서명 � 기재되었습니�.

Judith Weinstein, Senior Vice President, General Counsel et Corporate Secretary de Phibro Animal Health Corp (PAHC), s'est vu attribuer le 15/08/2025 3 447 unités d'actions restreintes (RSU). Chaque RSU confère un droit conditionnel à recevoir une action de catégorie A et la détention déclarée après l'attribution est de 3 447 actions (directes). Les RSU acquièrent des droits en parts sensiblement égales à chacun des trois premiers anniversaires du 1er août 2025, sous réserve de la poursuite de l'emploi jusqu'à chaque date d'acquisition. Le formulaire 4 a été signé et daté le 19/08/2025.

Judith Weinstein, Senior Vice President, General Counsel und Corporate Secretary von Phibro Animal Health Corp (PAHC), erhielt am 15.08.2025 3.447 Restricted Stock Units (RSUs). Jede RSU gewährt bedingt das Recht, eine Aktie der Klasse A zu erhalten; der nach der Zuteilung gemeldete Bestand beträgt 3.447 Aktien (direkt). Die RSUs werden in annähernd gleichen Teilen an jedem der ersten drei Jahrestage des 1. August 2025 unverfallbar, vorausgesetzt, die Beschäftigung besteht bis zu jedem Vesting-Datum fort. Das Formular 4 wurde am 19.08.2025 unterzeichnet und datiert.

Positive
  • 3,447 RSUs granted to a named officer, clearly disclosed
  • Vesting schedule specified: substantially equal installments on each of the first three anniversaries of 08/01/2025
  • Direct beneficial ownership after grant explicitly reported as 3,447 shares
Negative
  • None.

Insights

Routine equity grant to an officer; limited near-term market impact.

The filing documents a standard equity compensation award of 3,447 RSUs to the company's Senior Vice President and General Counsel. The award vests over three annual installments beginning August 1, 2025, and is recorded as a direct beneficial ownership of 3,447 shares following the grant. There are no sales, option exercises, or cash proceeds reported. From a market perspective, this transaction is a routine internal compensation action and does not by itself signal changes to corporate strategy, capital structure, or liquidity.

Compensation disclosure consistent with standard governance and disclosure practices.

The Form 4 correctly discloses an RSU grant to an officer and specifies vesting mechanics: substantially equal installments on each of the first three anniversaries of the specified vesting commencement date. The disclosure identifies the reporting person and her role. The submission appears complete for a Section 16 insider grant and provides the required details for investor transparency regarding insider holdings and potential future dilution as RSUs convert to shares upon vesting.

Judith Weinstein, Senior Vice President, General Counsel e Corporate Secretary di Phibro Animal Health Corp (PAHC), ha ricevuto in data 15/08/2025 3.447 unità azionarie vincolate (RSU). Ogni RSU dà diritto, al verificarsi della condizione prevista, a ricevere una azione di classe A e, dopo la concessione, la partecipazione segnalata è di 3.447 azioni (dirette). Le RSU maturano in quote sostanzialmente uguali in ciascuno dei primi tre anniversari dell'1 agosto 2025, subordinatamente alla permanenza in servizio fino a ciascuna data di maturazione. Il Modulo 4 è stato firmato e datato 19/08/2025.

Judith Weinstein, Senior Vice President, General Counsel y Corporate Secretary de Phibro Animal Health Corp (PAHC), recibió el 15/08/2025 3.447 unidades de acciones restringidas (RSU). Cada RSU confiere el derecho contingente a recibir una acción de la clase A y la tenencia reportada tras la concesión es de 3.447 acciones (directas). Las RSU se consolidan en partes aproximadamente iguales en cada uno de los tres primeros aniversarios del 1 de agosto de 2025, condicionadas a la continuidad en el puesto hasta cada fecha de consolidación. El Formulario 4 fue firmado y fechado el 19/08/2025.

주디� 와인스타�은 Phibro Animal Health Corp (PAHC)� 수석부사장 � 법무총괄·회사 비서로서 2025� 8� 15일에 3,447개의 제한부 주식 단위(RSU)� 부여받았습니다. � RSU� 조건부� 클래� A 보통� 1주를 수령� 권리� 의미하며, 부� � 신고� 보유 주식은 3,447�(직접 보유)입니�. RSU� 2025� 8� 1일을 기준으로 � 3� 기념� 각각� 거의 동일� 비율� 베스팅되�, � 베스팅일� 계속 고용 상태� 있어� 합니�. Form 4� 2025� 8� 19� 서명 � 기재되었습니�.

Judith Weinstein, Senior Vice President, General Counsel et Corporate Secretary de Phibro Animal Health Corp (PAHC), s'est vu attribuer le 15/08/2025 3 447 unités d'actions restreintes (RSU). Chaque RSU confère un droit conditionnel à recevoir une action de catégorie A et la détention déclarée après l'attribution est de 3 447 actions (directes). Les RSU acquièrent des droits en parts sensiblement égales à chacun des trois premiers anniversaires du 1er août 2025, sous réserve de la poursuite de l'emploi jusqu'à chaque date d'acquisition. Le formulaire 4 a été signé et daté le 19/08/2025.

Judith Weinstein, Senior Vice President, General Counsel und Corporate Secretary von Phibro Animal Health Corp (PAHC), erhielt am 15.08.2025 3.447 Restricted Stock Units (RSUs). Jede RSU gewährt bedingt das Recht, eine Aktie der Klasse A zu erhalten; der nach der Zuteilung gemeldete Bestand beträgt 3.447 Aktien (direkt). Die RSUs werden in annähernd gleichen Teilen an jedem der ersten drei Jahrestage des 1. August 2025 unverfallbar, vorausgesetzt, die Beschäftigung besteht bis zu jedem Vesting-Datum fort. Das Formular 4 wurde am 19.08.2025 unterzeichnet und datiert.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Weinstein Judith

(Last) (First) (Middle)
300 FRANK W. BURR BLVD., STE 21

(Street)
TEANECK NJ 07666

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock(1) 08/15/2025 A 3,447(2) A $0 3,447 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to the Reporting Person's continued employment through the applicable vesting date.
Remarks:
Senior Vice President, General Counsel and Corporate Secretary.
/s/ Judith Weinstein 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Judith Weinstein report on Form 4 for PAHC?

The Form 4 reports a grant of 3,447 restricted stock units (RSUs) to Judith Weinstein, Senior Vice President, General Counsel and Corporate Secretary.

When was the transaction date and when was the Form 4 signed?

The transaction date is 08/15/2025 and the Form 4 was signed on 08/19/2025.

What is the vesting schedule for the RSUs?

The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to continued employment through each vesting date.

How many shares does Weinstein beneficially own following the grant?

The filing reports 3,447 shares beneficially owned following the reported transaction, held directly.

What type of security was reported on the Form 4?

The reported securities are Class A Common Stock RSUs, each representing a contingent right to one share of Class A common stock.
Phibro Animal

NASDAQ:PAHC

PAHC Rankings

PAHC Latest News

PAHC Latest SEC Filings

PAHC Stock Data

1.27B
20.22M
0.59%
104.36%
2.53%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
United States
TEANECK